Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Resistance, Viral / genetics*
  • Female
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Male
  • Nucleosides / therapeutic use*

Substances

  • Antiviral Agents
  • Nucleosides